APA

Dimopoulos M. A., Kastritis E., Michalis E., Tsatalas C., Michael M., Pouli A., Kartasis Z., Delimpasi S., Gika D., Zomas A., Roussou M., Konstantopoulos K., Parcharidou A., Zervas K. & Terpos E. (20120612). The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Dimopoulos M A, Kastritis E, Michalis E, Tsatalas C, Michael M, Pouli A, Kartasis Z, Delimpasi S, Gika D, Zomas A, Roussou M, Konstantopoulos K, Parcharidou A, Zervas K and Terpos E. 20120612. The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Dimopoulos M. A., Kastritis E., Michalis E., Tsatalas C., Michael M., Pouli A., Kartasis Z., Delimpasi S., Gika D., Zomas A., Roussou M., Konstantopoulos K., Parcharidou A., Zervas K. and Terpos E. (20120612). The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Dimopoulos M A, Kastritis E, Michalis E, Tsatalas C, Michael M, Pouli A, Kartasis Z, Delimpasi S, Gika D, Zomas A, Roussou M, Konstantopoulos K, Parcharidou A, Zervas K and Terpos E. The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function. : Annals of oncology : official journal of the European Society for Medical Oncology. 20120612.